EXCiPACT™ GMP certified produced cell culture media
A crucial step when developing new drugs and cell therapies and during development of new cosmetics or cell-based food production, is the translation of a technology from the research laboratory to clinical use in the real world, and subsequently commercial manufacturing. To ensure this step goes well, understanding and evaluating potential raw material risks of media and reagents is key when working with products in a regulated environment….
Go To Page
Discover PromoCell’s new media & reagents specifications guide
We support you in choosing the right environment for your primary cell culture based on a streamlined definition guidance of PromoCell’s cell culture media and reagents….
Go To Page
GMP grade cell culture – infographic and expert interview
Good manufacturing practice (GMP) guidelines are particularly important for the media and reagents used in the development and manufacture of cell therapies. Gain expert insight and download our comprehensive infographic….
Go To Page
PromoCell is now EXCiPACT™ GMP certified
We have successfully completed a comprehensive EXCiPACT™ audit that certifies PromoCell as a manufacturer of pharmaceutical excipients to Good Manufacturing Practice (GMP) standards. This means we can now provide tailor-made cell culture media and reagents based on your regulatory requirements….
Go To Page
3D cancer model
De-skilling 3D tumor models Tissue-engineered 3D cancer models have grown in popularity with recent advances in cancer research. 3D models are more biomimetic than 2D cell monolayers cultured on tissue culture plastic. Examples are spheroids, tumorspheres, organoids, PDX and lately, tumoroids, which differ by origin (cell line or patient-derived), size, the complexity of cellular architecture and tumor environment….
Go To Page
Compliance
Our commitment to quality To do great research, you need high-quality products you can trust. That’s why we’ve put quality and reliability at the heart of our business for over 30 years. Our portfolio includes over 400 human cell culture products including primary cells, stem cells, blood cells, and optimized cell growth and differentiation media….
Go To Page
Custom Solutions
Our custom services: Contact us via online form via email at custom.solutions@promocell.com or call +49 6221 649 34 0 to let us know your requirements. We’ll be more than happy to discuss the possibilities with you. Why PromoCell? Our support team, consisting of highly qualified PhD scientists, is devoted to providing you with the highest level of personalized service available in the market….
Go To Page
Cell-based Manufacturing Media Platform
A GMP-compliant, customizable Manufacturing Media Platform (MMP) providing broad support for the serum-free culture of sophisticated cells used to manufacture cell-based products in a regulated environment. Currently the development of new therapeutic interventions often uses mammalian cells as an integral tool in the manufacturing process. However, the function of cells within these processes may differ substantially….
Go To Page
PromoCell now exclusive supplier of MATra (Magnet-Assisted Transfection)
Primary cells can prove much more difficult to transfect than other commonly used cell lines. While high transfection efficiencies are possible using commercially available transfection reagents in diverse, commonly used cell lines, primary cells but also diverse cell lines have proven much more difficult to transfect….
Go To Page
PromoCell receive Germany’s TOP JOB award yet again
We couldn’t be prouder of our staff, who make PromoCell such a great place to work….
Go To Page
Clinically relevant cell culture tools for COVID-19 research
As the global COVID-19 pandemic evolves, researchers worldwide are working hard to study the mechanisms underlying SARS-CoV-2 infection. Thanks to their discoveries, new insights for developing treatments, vaccines and diagnostic tools are being made possible….
Go To Page
Cancer stem cell selection
Advance cancer stem cell culture Cancer stem cells (CSCs) are a specific and small subpopulation of tumor cells. Despite their low number, they drive tumor initiation, influence tumor progression, and cause metastasis and relapse. Increased cancer stem cell populations have been shown to reflect the aggressiveness and therapy-resistant phenotype of the tumor….
Go To Page